Commodore Capital - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2019
Commodore Capital is a healthcare investment firm focused on early-stage biopharmaceutical innovations. The firm specializes in investing in companies developing novel therapeutic modalities such as genetic medicines and cellular therapies. Commodore Capital believes that the industry is in the early stages of a major innovation cycle, with significant breakthroughs occurring in smaller biopharma companies.
The firm's portfolio includes notable companies like Adarx Pharmaceuticals, Cogent Biosciences, and Nimbus Therapeutics. Commodore Capital invests across various stages, from seed to post-IPO equity rounds, demonstrating a commitment to supporting companies throughout their growth journey. Their investment strategy focuses on improving patients' lives through innovative biopharmaceutical advancements.
Commodore Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages